European IPO Activity Picks Up — At a Glance
A number of companies across Europe set out plans to launch initial public offerings on European stock exchanges in recent weeks, paving the way for a revival in listings after a prolonged lull.
-- French software company Planisware said Tuesday that it intends to float on Euronext Paris at an offering price valuing the group at 1.11 billion euros ($1.18 billion).
-- Global buyout firm CVC Capital Partners said Monday that it plans to list its shares in Amsterdam in the coming weeks, making a second attempt to go public in less than six months.
-- Jean Paul Gaultier owner Puig Brands said last week it aims to list in Madrid and other Spanish stock exchanges through a EUR3 billion stock sale. The offering would be the biggest in Spain since 2015
-- Swiss skin-care specialist Galderma Group--backed by European buyout firm EQT--made its debut in the Zurich stock exchange in March, reaching a market value of about 14.75 billion Swiss francs ($16.44 billion).
-- German cosmetics and perfume retailer Douglas--backed by buyout giant CVC Capital Partners--started trading on the Frankfurt Stock Exchange last month too, but as of Monday's close its shares were down nearly 26% compared with its IPO price.
Other companies said they intend to seek listings in the future, but haven't started formal processes yet. This is the case for Spanish fashion retailer Tendam, which houses brands such as Women'secret, Springfield, Cortefiel and Pedro del Hierro. The company said Monday that it intends to launch an IPO in its current fiscal year, which ends in February.
Earlier this month, Airbus unit Aalto HAPS, which develops high-altitude drones that offer mobile connectivity and Earth observation services, told The Wall Street Journal that it could consider an IPO after it launches commercial operations in the coming years.
Write to Barcelona editors at barcelonaeditors@dowjones.com
(END) Dow Jones Newswires
April 16, 2024 07:52 ET (11:52 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track